Coronary Artery Disease (CAD) - Pipeline Review, H1 2012 New Report
Coronary Artery Disease (CAD) - Pipeline Review, H1 2012, provides an overview of the Coronary Artery Disease (CAD) therapeutic pipeline. This report provides information on the therapeutic development for Coronary Artery Disease (CAD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Coronary Artery Disease (CAD). 'Coronary Artery Disease (CAD) - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s...
View full press release